PharmStockPharmacy Stock

Ranexa
Ranexa

1.52
A generic medicine indicated for blood pressure and heart conditions. Modulates sodium channels in cardiac cells to ease pressure on the heart and optimize blood flow.
Ingredient
Ranolazine
Category
Heart & Blood Pressure
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Ranolazine
Reference Brand
Ranolazine
Product Origin
Generic Alternative
Reference Manufacturer
Gilead Sciences
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Antihypertensives
Product Category
Piperazine Derivative
Pharmacological Class
Antianginal Agent
Clinical Indications
Chronic angina
Manufacturer Description
Developed to mitigate ischemic cardiac strain to support coronary performance and alleviate chronic chest pain.
Mechanism of Action
Selectively inhibits the late sodium current in myocardial cells, preventing intracellular calcium overload to relax muscles.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
12 hours
Contraindications
Severe hepatic impairment, Concurrent strong CYP3A4 inhibitors
Severe Adverse Events
QT prolongation — requires immediate medical attention
Common Side Effects
Dizziness, Headache, Constipation
Uncommon Side Effects
Nausea, Palpitations, Weakness
Drug Interactions
Ketoconazole, Clarithromycin, Simvastatin
Pregnancy Safety Warnings
TGA Category C: Use if potential benefit outweighs risk. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Imdur
Information related to Ranexa is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to purchase Antiviral Hepatitis Australia - Buy Entecavir AU